CraniUS Plate
CraniUS, LLC · Decision date Sep 11, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the CraniUS Plate, submitted by CraniUS, LLC of Baltimore, Maryland, under 510(k) number K262874. The decision date is September 11, 2026; the submission was received August 14, 2026. The device is a Class II preformed alterable cranioplasty plate under 21 CFR 882.5320, product code GWO, in the Neurology specialty. SESE means clearance to market, not premarket approval.
The CraniUS Plate is a patient-specific PEEK implant intended to fill a bony void or defect in the cranial skeleton, fixed with separately cleared cranial fixation screws and plates and supplied non-sterile. The 510(k) summary identifies K261058 (also named CraniUS Plate) as the predicate, with the same indications, material, size range and thickness. The stated change is an added optional opening pattern for an implantable intracranial pressure sensor, requested by the surgeon; reservoirs and sensors are not included. The summary reports biocompatibility, cleaning and sterilization, and mechanical testing, but the source does not give detailed test results or the full indications wording.
The letter text carries an internal date inconsistency, showing September 11, 2029 in one place, while the database and signature record September 11, 2026. No clinical outcome data are provided in the available excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 11, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262874
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- CraniUS, LLC
- Product code
- GWO
- Decision code
- SESE
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Plate, Cranioplasty, Preformed, Alterable.
- Applicant
- CraniUS, LLC
- Product code
- GWO
- FDA device class
- 2
FDA decision timeline
K262874 received
Application receipt date recorded by FDA.
K262874 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
CraniUS, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Baltimore, MD
Sources and methodology
- Original FDA record: K262874
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records